Global hunt for answers on new bladder cancer drug duo
Disease control
Not yet recruiting
This study is looking back at the real-world results of a two-drug combination (enfortumab vedotin plus pembrolizumab) used as the first treatment for people with advanced bladder cancer that has spread. It aims to collect information from around the world to see how long patient…
Sponsor: Aron Research Foundation Ets • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC